PharmExec Direct, Sep 10, 2009 - Pharmaceutical Executive

ADVERTISEMENT

PharmExec Direct, Sep 10, 2009
News Analysis
Sepracor Faces Shareholder Lawsuit in Wake of $2.6B Deal
By George Koroneos, Online Content & News Editor
Some shareholders think they were shafted in the multi-billion dollar deal between Sepracor and Dainippon Sumitomo Pharma. They're so miffed, in fact, that they've filed a lawsuit stating that the amount offered undervalues the company and its shares.
Roche Shifts Execs in Anticipation of Departures
By George Koroneos, Online Content & News Editor
With the pending retirement of three senior-level executives, Roche announced a new corporate executive team to bridge the personnel gap while the company looks for new leaders.
UK Pharmacies Dealing with Drug Shortages
By Sarah Houlton
With a weak pound being outpaced by the euro, many hospitals are sending drugs to the Continent for higher profits. What can NHS do to stop this practice?

ADVERTISEMENT

Click here